The Clemson University Research Foundation is pleased to introduce Dr. Alan Alfano, the newest member of the CURF team. Dr. Alfano will be working as a Technology Commercialization Officer (TCO) with Clemson inventors on biomedical, bioengineering, and life sciences technologies, among others.
Alan completed a dual BS degree from Towson University (Molecular Biology/Chemistry) in 2009, and subsequently earned his Ph.D. from the University of Maryland, School of Medicine (Molecular Medicine) in 2015. His thesis work focused on drug resistance and metastatic spread of aggressive prostate cancer. During his time as a Ph.D. student at UMSOM, Alan also completed a technology development internship with UMVentures (UMB Technology Transfer Office), where he assisted senior staff in conducting commercial analysis and targeted marketing of selected technologies.
Following completion of his Ph.D. work at UMSOM, Alan completed a post-doctoral Cancer Research Training Award (CRTA) Fellowship at the National Cancer Institute Technology Transfer Center (NCI-TTC). As a fellow at NCI TTC, Alan worked to perform a variety of invention development activities for clinicians and researchers at the NIH/NCI Center for Cancer Research. His primary subject areas of invention management/expertise include: oncology (general), experimental transplants, immunology and immunotherapeutics (e.g. novel antibodies, CARs, ADCs, RITs, etc.), vaccine development, radiation oncology, molecular diagnostics, genetics, and software/digital solutions.
Through his work in disease research, and his biotech business experience at UMB and NCI, Dr. Alfano has developed skills that will enable him to learn and adapt quickly in his new role as a Technology Commercialization Officer (TCO) with CURF.